Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Clinical trial NCT04233866 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04233866
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2026-03-02
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.